Categories: News

Coherus Management to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March.

  • 41st Annual Cowen Healthcare Conference on Monday, March 1 at 4 p.m. ET
  • Barclays Global Healthcare Conference on Tuesday, March 9 at 1:15 p.m. ET

The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.

For additional information, please visit www.coherus.com.

Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152

 

Staff

Recent Posts

IntelePeer Agentic AI Trend Report Cites Trust, Day-One Value, Integration, and Analytics as Critical Success Factors in Healthcare Deployments

2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…

2 hours ago

IntelePeer Agentic AI Trend Report Cites Trust, Day-One Value, Integration, and Analytics as Critical Success Factors in Healthcare Deployments

2026 Outlook: automated Agentic AI workflows will rapidly emerge as business imperatives to meet patient…

2 hours ago

Netsmart Strengthens Interoperability Leadership Through CMS Health Technology Ecosystem Pledge

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#CMSAlignedNetwork--Netsmart, an industry-leading provider of healthcare technology solutions and services for community-based…

2 hours ago

The Naderi Center Announces the Rise of “Facial Harmony” as 2025’s Leading Trend in Aesthetic Surgery and Dermatology

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are…

2 hours ago

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

5 hours ago